United States · Platforms & data · Stocktwits

BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial

Published by Stocktwits · United States 8 h ago

Shares of Bristol Myers Squibb (BMY) dropped 2% on Friday after the company disclosed a patient death in its early-stage Breakfree-2 study of the experimental CAR T cell therapy,…

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading

Seeking Alpha

Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders

BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial

Share

Also worth reading

Tech stocks weigh on Nasdaq for second week; Roper leads gainers

Split $5,000 Across These 5 Dividend Stocks and Don't Look Until 2031

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

After previous day’s slump, trading is quieter among AI shares

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders